6IAP

structure of human NKp46 in complex with antibody NKp46-1 and NKp46-4


Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 2 48494
95 % 2 2 31903
90 % 2 2 30640
70 % 2 2 36983
50 % 2 2 32054
40 % 22 33 1474
30 % 27 40 1263
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74864
95 % 1 1 61669
90 % 337 594 4
70 % 1591 2557 2
50 % 4051 6625 1
40 % 4052 6626 1
30 % 4081 6673 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74863
95 % 1 1 61668
90 % 1 1 58106
70 % 1940 3169 1
50 % 4052 6625 1
40 % 4053 6626 1
30 % 4082 6673 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74866
95 % 2 2 37321
90 % 2 2 35688
70 % 1941 3169 1
50 % 4053 6625 1
40 % 4054 6626 1
30 % 4083 6673 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 2 48495
95 % 9 10 5894
90 % 338 594 4
70 % 1592 2557 2
50 % 4054 6625 1
40 % 4055 6626 1
30 % 4084 6673 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 6UCF 1 L N123-VRC34_pI4 light chain 9606
3 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
4 6MEE 2 B, D antibody HEPC74 Light Chain 9606
5 6UCE 1 L N123-VRC34_pI3 light chain 9606
6 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
7 5UCB 2 L Fab Light Chain 9606
8 5I8C 2 B VRC34.01 Fab light chain 9606
9 5WK2 1 L M116 LIGHT CHAIN 9606
10 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
11 5VSI 2 L CH1/Ckappa Fab light chain 9606
12 6PZG 1 L NA-80 Fab light chain 9606
13 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
14 4NWU 2 L APE1551 Ab Fab light chain 9606
15 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
16 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
17 5OB5 3 L fAb Light chain 9606
18 5UEA 3 B, L Fab Light Chain 9606
19 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
20 3NCJ 1 L Fab15 Mut8 light chain 9606
21 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
22 4NWT 1 L APE1531 Ab Fab light chain 9606
23 3NA9 1 L Fab15 light chain 9606
24 5U6A 1 A Light Chain 9606
25 6K0Y 2 B Antibody Light Chain 9606
26 5UEK 3 L Fab 12E Light Chain 9606
27 3NAA 1 L Fab15 Mut5 light chain 9606
28 5IK3 2 B, D 1E03 Fab fragment light chain 9606
29 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
30 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
31 5IT2 2 L light chain 9606
32 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
33 6DW2 1 A 6078 Fab light chain 9606
34 6BQB 1 L MGG4 Fab light chain 9606
35 4PUB 2 L DX-2930 LIGHT CHAIN 9606
36 6B14 2 L Light chain of Fab BL3-6S97N 10090
37 5VKD 3 L Fab light chain 9606
38 5XHG 1 A, C polypeptide(L) 10090
39 3OAZ 2 K, L Fab 2G12, light chain 9606
40 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
41 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
42 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
43 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
44 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
45 4JHA 2 L D25 light chain 9606
46 6B9Z 1 A Trastuzumab Fab light chain 10090
47 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
48 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
49 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
50 6PEC 1 L antibody light chain 9544
51 6PE7 2 L FAB Light chain 9606
52 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
53 7BZ5 3 L Light chain of B38 9606
54 6NYQ 1 L 1H3 Fab light chain 10090
55 6IAS 2 L Fab NKp46-1 light chain 32630
56 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
57 3P0Y 3 L Fab DL11 light chain 9606
58 6ANA 3 L LL2 Fab Light Chain 10090
59 6AOD 1 A FXIa Antibody FAB Light Chain 9606
60 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
61 6ELE 2 B, L fAB light chain 9606
62 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
63 3NAC 1 L Fab15 Mut7 light chain 9606
64 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
65 3EO9 1 L Efalizumab Fab fragment, light chain 9606
66 6N35 1 K, L Fab 2G12 light chain 9606
67 5WUV 1 L light chain 9606
68 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
69 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
70 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
71 6D0X 2 B 1210 Antibody, light chain 9606
72 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
73 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
74 6O39 1 A Antibody F2.I Fab, Light chain 9606
75 5XKU 2 B HNIgGA6 light chain 9606
76 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
77 5I18 1 L FAB LIGHT CHAIN 9606
78 3SOB 1 L antibody light chain 9606
79 6B5M 2 L CIS43 Fab Light chain 9606
80 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
81 4KQ3 1 L CNTO3186 light chain Fab 9606
82 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
83 4I77 2 L Lebrikizumab light chain Fab 9606
84 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
85 4HJG 1 A Trastuzumab light chain 9606
86 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
87 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
88 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
89 6ELJ 2 B, L fAB light chain 9606
90 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
91 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
92 6CBV 2 L Light Chain, Fab fragment 9606
93 5JW5 2 B, L MEDI8852 Light chain 9606
94 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
95 3QWO 1 B, L motavizumab light chain 10090
96 4IOI 1 A Trastuzumab light chain 9606
97 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
98 5VAG 2 B Light chain of antibody m826 9606
99 4RBP 1 K, L Fab 2G12 light chain 9606
100 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
101 6B5N 2 L CIS43 Fab Light chain 9606
102 3OAY 1 K, L Fab 2G12, light chain 9606
103 6AND 3 L Pinatuzumab Fab light chain 9606
104 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
105 5F7E 2 L Fab light chain 9606
106 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
107 5FHA 2 L Antibody 114 Fab light chain 9606
108 5UMN 3 D, F Antibody C05, light chain 9606
109 4X7S 2 L Ig kappa chain C region residues 23-236 9606
110 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
111 3QPQ 1 C, E, I, L C1068 light chain 10090
112 6PHB 2 A, C 2530 Antibody Fab, Light Chain 9606
113 6MXR 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
114 6ELL 2 B, L fAB light chain 9606
115 2HFF 1 A, L CB2 Fab, light chain 9606
116 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
117 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
118 6MXS 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
119 5I1L 1 A, L FAB LIGHT CHAIN 9606
120 5GGV 1 L light chain 9606
121 3L5X 1 L H2L6 LIGHT CHAIN 9606
122 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
123 2R8S 2 L Fab light chain 10090
124 4HKZ 1 A Trastuzumab light chain 9606
125 6DB8 3 L Fab-Light chain 32630
126 6DDR 1 A Anti-MICA Fab fragment light chain clone 13A9 10090
127 6MEH 3 L antibody HEPC74 Light Chain 9606
128 6O23 2 B, D 2243 kappa light chain 9606
129 3OAU 2 L Fab 2G12, light chain 9606
130 5WEQ 1 A MR78 mutant light chain 9606
131 6TCQ 2 L Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant Omalizumab Fab Ser81Arg and Gln83Arg light chain mutant 9606
132 4ZYK 2 B, L AM14 light chain 9606
133 6DWA 1 A, L 4497 Fab Light Chain 9606
134 5E94 1 A, C Antibody Fab fragment light chain 10090
135 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090
136 6MED 2 B, D, I antibody HEPC3 Light Chain 9606
137 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
138 6ME1 2 B, D VRC34.01 Fab light chain 9606
139 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
140 4KMT 1 L light chain O12/KAPPA Fab 9606
141 6U3Z 2 B, D V20_5A4 Light Chain Fab 9544
142 6CW3 2 B, D antibody light chain 9606
143 6BTJ 2 B, L Light chain of H7.5 Fab 9606
144 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
145 4XTR 3 D, F Antibody Light chain 32630
146 1RZ7 1 L Fab 48d light chain 9606
147 1RZG 2 B, D Fab 412d heavy chain 9606
148 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
149 3PGF 3 L SAB Light Chain 9606
150 6B9Y 1 A Trastuzumab Fab light chain 9606
151 2QQN 3 L Antibody light chain 9606
152 6MSY 1 L Fab 2G12, light chain 9606
153 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
154 6BAE 1 A Trastuzumab Fab light chain 10090
155 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
156 2CMR 3 L D5 9606
157 5ZV3 3 L Light chain (kappa) of antibody CBTAU28.1 9606
158 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
159 5CZX 3 D, L 20358 Fab light chain 9606
160 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
161 3GRW 2 L Fab light chain 9606
162 6B3K 2 L Light chain of Fab BL3-6 10090
163 5I1D 1 A, L FAB LIGHT CHAIN 9606
164 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
165 6AYZ 2 C, D Fab Light Chain 9606
166 6O3A 1 A Antibody F7.B Fab, Light chain 9606
167 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
168 4LKC 1 A Fab fragment of PCSK9 antibody 9606
169 4KZD 2 L BL3-6 Fab antibody, light chain 10090
170 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
171 6O1F 4 L Light Chain hu31A.v11 9606
172 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
173 5IES 2 L VRC01cHuGL2 Fab light chain 9606
174 6OCB 2 L Light chain of FluA-20 Fab 9606
175 6RCS 2 B R5.016 light chain 9606
176 3S34 1 L 1121B Fab light chain 10090
177 6B6Z 1 A, C Apo Fab Light Chain 9606
178 6EMJ 2 B, L fAb light chain 9606
179 5W1G 2 L CR1-07 Fab light chain 9606
180 6CNR 1 L Aducanumab light chain 9606
181 6PLK 2 L, M ZIKV-116 light chain 9606
182 6OKM 2 L Fab 3C8 light chain 9606
183 4NRX 3 B, E, L m66 Light Chain 9606
184 3O2D 1 L ibalizumab light chain 10090
185 6DB9 3 L Fab-Light-Chain 32630
186 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
187 5O14 3 D, L Fab 1A12 Light Chain 9606
188 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
189 6B5O 2 L CIS43 Fab Light chain 9606
190 2R0L 1 L antibody light chain 32630
191 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
192 6N32 1 L, M Fab 2G12 light chain 9606
193 6TYB 4 L NEUTRALIZING ANTIBODY ITS90.03 FAB LIGHT CHAIN 9544
194 6DWC 1 A, L 4497 Fab Light Chain 9606
195 6VBP 1 B, D, I, L DH815 light chain 9606
196 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
197 5VZ1 1 A, C Apo Antibody Fab Light Chain 9606
198 5OD8 2 B B2 Fab fragment - Light chain 9606
199 3KR3 3 L antibody-Fab (light chain) 9606
200 6DZN 1 L Antibody ADI-15878, light chain 9606
201 5GGU 2 B, L light chain 9606
202 5KW9 3 L IgA Light chain 9606
203 6TCN 1 A, L Omalizumab Fab Omalizumab Fab light chain 9606
204 6XXV 2 B, E Antibody C57, Light Chain 9606
205 5W2B 2 L Fab Light Chain 9606
206 6E4X 2 Y S5V2-29 light chain 9606
207 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
208 6AXL 1 B, C Fab317 light chains 9606
209 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090
210 6HIG 2 L Light Chain 10090
211 6CXG 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
212 6CO3 1 L Fab light chain 9606
213 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
214 3BN9 2 C, E E2 Fab Light Chain 9606
215 6DZR 2 L h38c2 light chain 9606
216 6U9U 2 L GM9_TH8seq732127 FAB light chain 9606
217 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
218 4OGX 3 L DX-2930 LIGHT CHAIN 9606
219 4KZE 2 L BL3-6 Fab antibody, light chain 10090
220 6NHA 3 L SYNT001-Fab light chain 9606
221 6MU3 1 K, L Fab 2G12, light chain 9606
222 4XVU 3 D, F, J, L Antibody light chain 32630
223 5B71 1 A, C SKY59 Fab light chain 9606
224 6BF4 3 C, L VRC-PG05 Fab light chain 9606
225 3NAB 1 L Fab15 Mut6 light chain 9606
226 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
227 4WV1 3 A, D Fab light chain 9606
228 5EII 2 B, L Fab Light Chain 9606
229 4FNL 2 L, M Antibody C05, Light Chain 9606
230 4UB0 2 L IgG1, light chain 9606
231 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
232 1BJ1 1 J, L Fab fragment, light chain HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
233 6BFT 1 B, L Avastin Light Chain Fab fragment mutant 9606
234 3IDX 3 L Fab b13 light chain 9606
235 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
236 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
237 6B5L 2 L CIS43 Fab Light Chain 9606
238 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
239 5VEB 2 B, L anti-CDH6 Fab light chain 9606
240 6N81 2 D, L A1227 Fab light chain 9606
241 5E08 2 L Fab Light Chain 9606
242 6AZ2 3 E, F Fab Light Chain 9606
243 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
244 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
245 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
246 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
247 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
248 4EDW 2 L tanezumab Fab light chain 9606
249 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
250 6YLA 3 C, L Light chain 9606
251 4NM4 1 L, M Antibody CR8043, Light Chain 9606
252 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
253 4G7V 2 L fragment antibody light chain 9606
254 4HFW 1 A, L 6-26 Fab Light chain 9606
255 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
256 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
257 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
258 5JO4 4 D G6 Fab Light Chain 9606
259 3INU 2 L, N KZ52 antibody fragment light chain 9606
260 5EU7 3 C, D FAB light chain 9606
261 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
262 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
263 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
264 6X5M 1 L, l Light chain Fab BL-3 6 10090
265 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
266 3EYV 1 A, L hu3S193 Fab, light chain 10090
267 6Q20 2 L 1E01 Fab kappa light chain 9606
268 5IJK 3 C, D 1E03 Fab fragment light chain 9606
269 3BDY 2 L Fab Fragment -Light Chain 9606
270 5I8E 2 B, D VRC34.01 Fab light chain 9606
271 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
272 5UIX 2 L DH576 Fab light chain 9606
273 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
274 6TCP 1 A, C, E, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
275 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
276 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
277 2HFG 1 L CB3s Fab light chain (kappa) 9606
278 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
279 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
280 5ZIA 2 B, E, I, L, M, P Light chain (kappa) of CBTAU-24.1 antibody 9606
281 4JQI 3 L Fab30 light chain 10090
282 6B0H 3 A, C 1262 antibody, light chain 9606
283 6U8C 2 C, L Antibody light chain Fab 9606
284 3SKJ 1 L, M Antibody, light chain 9606
285 3U30 2 B, E Light chain Fab 9606
286 6ULE 2 B, D 2541 Antibody, light chain 9606
287 6MFJ 2 B, L DH677.3 Fab light chain 9606
288 5HYS 2 B, D, F, L Uncharacterized protein 9606
289 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
290 5I15 1 L FAB LIGHT CHAIN 9606
291 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
292 6U8K 3 E, G, L Light chain of Fab HCV3 Light chain of Fab HCV3 9606
293 5I1E 1 L FAB LIGHT CHAIN 9606
294 4JLR 2 B, L Motavizumab Fab light chain 9606
295 2QQK 3 L Antibody Light Chain 9606
296 4J1U 1 A, C, E antibody 93F3 Light chain 10090
297 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
298 5SX5 1 K, L Panitumumab Fab Light Chain 9606
299 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
300 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
301 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
302 5BK2 3 D, L sAB Light Chain 9606
303 1TZH 2 A, L Fab YADS1 Light Chain 10090
304 5O1R 3 L, M Uncharacterized protein 9606
305 4JZJ 3 B, L Fab Light Chain 10090
306 5BO1 3 L, M Fab light chain 9606
307 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
308 6Z2M 3 C, L CR3022 antibody 9606
309 4M6O 1 L CNTO7309 light chain 9606
310 5LSP 3 L, T 107_A07 Fab light chain 9606
311 6MWN 3 D, L Fab HAVx Light Chain 9606
312 4DVR 2 L Fab 48d Light chain 9606
313 6PI7 2 B, E Uncharacterized protein 9606
314 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
315 6HXW 3 D, L IPH53 light chain 32630
316 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
317 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
318 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
319 6BGT 2 A Herceptin light chain mutant 9606
320 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
321 3DVG 1 A Human IgG1 fab fragment light chain 9606
322 6ZCZ 4 L EY6A light chain 9606
323 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
324 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
325 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
326 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
327 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
328 2FJG 2 A, L Fab light chain 9606
329 4DKF 3 L, M FAb2 Light Chain 9606
330 5TLK 3 C, G H2191 LIGHT CHAIN 10090
331 6OGX 2 D Fab1 Light Chain 9606
332 6OGX 5 L Fab2 light chain 9606
333 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
334 6MEJ 5 L antibody HEPC3 Light Chain 9606
335 3EFD 1 L FabL 10090
336 4LF3 1 A, D Fab heavy chain 10090
337 6IAP 2 D Fab NKp46-4 light chain 32630
338 6IAP 5 L Fab NKp46-1 light chain 32630
339 5K59 4 F, L Fab light chain 9606
340 6MUB 1 K, L Fab 2G12, light chain 9606
341 6BFQ 2 B, D, F, L Fab Light Chain 9606
342 6PZF 2 E, L NA-63 Fab light chain 9606
343 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
344 6O3B 1 A, E Antibody Fab F6, Light chain 9606
345 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
346 4LEO 2 B RG7116 Fab light chain 10090
347 4G7Y 2 L Fragment antibody light chain 9606
348 4PY8 4 J antibody 3.1 light chain Fab 9606
349 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
350 3IXT 1 B, L Motavizumab Fab light chain 10090
351 6FAX 1 L Lob 7.4 light chain 9606
352 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
353 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090
354 6U85 2 L antibody Fab Light chain 9606
355 5I1I 1 L FAB LIGHT CHAIN 9606
356 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
357 4ERS 1 L Fab light chain 9606
358 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
359 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
360 3SQO 3 L J16 Light chain 9606
361 4K3J 4 L Onartuzumab Fab light chain 10090
362 6PE8 2 B, L FAB Light chain 9606
363 6CYF 2 C, E, L, T IgG1 antibody, kappa light chain 9606
364 6MNF 1 K, L Fab 2G12, light chain 9606
365 4PY7 2 B, J antibody 3.1 light chain Fab 9606
366 6AL5 2 L B43 LIGHT CHAIN 9606
367 4K8R 3 C Fab1, light chain 9606
368 6P3R 2 B, D Human Fab H5.31 light chain 9606
369 6HHC 1 L FXIA ANTIBODY FAB LIGHT CHAIN 9606
370 6ML8 4 L C05 antibody Fab light chain 9606
371 1TZI 1 A Fab YADS2 Light Chain 10090
372 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
373 4X7T 2 B, L Omalizumab-Fab Light chain 9606
374 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
375 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
376 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
377 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
378 6MEI 3 L antibody HEPC3 Light Chain 9606
379 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
380 2QQL 3 L Antibody Light Chain 9606
381 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
382 5SX4 1 I, L Panitumumab Fab Light Chain 9606
383 3WD5 2 L Adalimumab Light Chain 9606
384 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
385 5GZO 3 D, L Antibody light chain 9606
386 6W16 3 L 458 Fab light chain 9606
387 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
388 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
389 7C01 3 D, L CB6 light chain 9606
390 4FP8 3 L, M, N, O Antibody C05, light chain 9606
391 6R2S 1 A Antibody DB9 light chain 9606
392 6I8S 3 I, J, K, L LIGHT CHAIN OF FAB FRAGMENT FROM AN PAI-1 ANTIBODY FAB FRAGMENT 9606
393 6CW2 4 B antibody light chain 9606
394 3BE1 3 L Fab Fragment-Light Chain 9606
395 2FJH 2 A, L Fab fragment light chain 9606
396 5XEZ 3 D, L Antibody, mAb1, light chain 9606
397 3P0V 1 L, M Fab DL11 light chain 9606
398 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
399 6OEL 5 L engineered Fab light chain 9606
400 6X5N 1 L, l Light chain Fab BL-3 6 10090
401 6UTE 2 B, D, F, H, J Z032 Fab light chain 9606
402 5VIG 2 B, L Fab light chain 9606
403 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
404 6I04 3 D, L Fab light chain 9606
405 5VYF 1 A, L Antibody light chain 10090
406 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
407 4K7P 4 L antibody 10C4 Fab fragment light chain 10090
408 5WUX 2 B, D, L light 9606
409 3OB0 1 K, L Fab 2G12, light chain Fab 9606
410 6MFP 4 D, L DH677.3 Fab light chain 9606
411 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
412 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
413 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
414 4I18 1 B, L antibody light chain Fab 10090
415 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
416 3IDY 3 C, L Fab b13 light chain 9606
417 3IVK 1 B, L Fab light chain man 10090
418 5I19 1 L FAB LIGHT CHAIN 9606
419 5TH9 1 L, M, N GS-5745 Fab light chain 9986
420 6OKN 2 B, D Fab 1A7 light chain 9606
421 6OC3 2 B, D Light chain of FluA-20 Fab 9606
422 6NZ7 4 I, L 429 B01 FAB light chain 9606
423 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
424 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
425 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
426 5FEC 2 B, L germline 3BNC60 light chain 9606
427 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
428 2R56 2 L, M IgE Fab Fragment, light chain 9606
429 1ZA6 1 A, C, E, G IGG Light chain 9606
430 4ZS6 1 D, L fab Light Chain 9606
431 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
432 6APB 3 L ADI-14359 Fab Light Chain 9606
433 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
434 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
435 6Q23 3 F, I, K, L 1G01 Fab kappa light chain 9606
436 5CZV 3 L Fab 20350 light chain 9606
437 5XF1 3 D, L Antibody mAb1 Light chain 9606
438 4P59 3 L MOR09825 Fab fragment light chain 9606
439 5XXY 2 L light chain of atezolizumab fab 9606
440 5CJO 3 L FAB light chain 10090
441 4LMQ 3 I, L Stromal cell-derived factor 1 9606
442 3N85 2 L Fab37 Light Chain 9606
443 3G6J 3 E, G Fab light chain 9606
444 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
445 6MH2 1 A, C Herceptin Fab arm light chain 9606
446 6K7O 3 C, E, G, L h128-3 Fab light chain 9606
447 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
448 5O4G 2 A MF3958 FAB light chain 9606
449 6PE9 2 B, D, F, L, M FAB Light chain 9606
450 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
451 4DKE 3 L, M FAb1.1 Light Chain 9606
452 6W41 2 L CR3022 Fab light chain 9606
453 5VIC 2 L Fab light chain 9606
454 6MEK 3 D, L HEPC3 Light Chain 9606
455 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
456 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
457 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
458 6Q1Z 2 C, L 1G04 Fab kappa light chain 9606
459 4NRY 1 B, L m66 Heavy Chain 9606
460 6OE4 2 C, F CR9501 Fab Light Chain 9606
461 6N2X 1 K, L Fab 2G12 light chain 9606
462 3S37 1 L 1121B Fab light chain 10090
463 5XHF 1 A, C polypeptide (L chain) 10090
464 5VL7 4 L Fab33 light chain 9606
465 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
466 6P8N 3 D, L P-p1f1 Light Chain 10090
467 6DEZ 1 A, L Anti-phosphotyrosine antibody PY20-4D5 light chain 32630
468 1S78 2 C, E Pertuzumab Fab light chain 10090
469 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
470 5D1Z 1 A, H Y10 Light Chain 9606
471 5D1Z 3 C, E D4-10 Light Chain 9606
472 4XHJ 3 C, G Fab-RC light chain 9606
473 5O4O 1 A MF3178 FAB light chain 9606
474 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
475 5D1Q 1 A D2-06 Light Chain 9606
476 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
477 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
478 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
479 5XHV 3 L, Q S40 light chain 9606
480 6YZ7 3 CCC, LLL Antibody light chain 9606
481 4IOF 3 D, F Fab-bound IDE, light chain 10090
482 6S3D 2 B, D, F, L Light Chain 9606
483 5FUO 3 L FAB LIGHT CHAIN 9606
484 4JHW 2 L D25 light chain 9606
485 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
486 6CXL 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
487 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
488 7BXA 3 C, L light chain 9606
489 4M1C 3 D, F Fab-bound IDE, light chain 9606
490 5UQY 3 C, G, K, O MR78 Fab light chain 9606
491 6D0U 3 D, F, I, L Antibody C05, light chain 9606
492 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
493 3ULV 2 L Fab15 light chain 9606
494 3ULV 6 E Fab1068 light chain 9606
495 6W7Y 2 B, L CR3022 Light chain 9606
496 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
497 6ZER 3 C, G, L light chain 9606
498 6OUS 4 N, P, R, T, V, X RB1 Fab Light chain 9606
499 6UTA 2 B, L Z004 iGL Fab light chain 9606
500 6P8M 3 L P-p3b3 Light Chain 10090
501 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
502 5UOE 3 L, N, Q, T, W FAB light chain 9606
503 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
504 5JW3 4 L MEDI8852 light chain 9606
505 6D11 2 B, D 1450 Antibody, Light chain 9606
506 3S36 1 L 1121B light chain 10090
507 5CWS 1 A, G sAB-158 Fab Light Chain 9606
508 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
509 2R0K 2 L antibody light chain of Fab58 9606
510 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
511 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
512 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
513 4G80 3 B, D, F, H fragment antibody light chain 9606
514 3JWO 3 L FAB 48D LIGHT CHAIN 9606
515 5CD5 3 D DRVIA7 Fab Light Chain 9606
516 3P11 2 L Fab DL11 light chain 9606
517 3ULU 2 L Fab15 light chain 9606
518 3ULU 6 E Fab1068 light chain 9606
519 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
520 4XI5 3 C Fab-94 light chain 9606
521 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
522 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
523 6EAY 1 L CA45 light chain 9541
524 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
525 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
526 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
527 6RCV 4 D, I R5.016 light chain 9606
528 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
529 5JW4 6 R MEDI8852 light chain 9606
530 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
531 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
532 5J3D 2 B, D, L 14N4 light chain 9606
533 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
534 3EFF 1 A, C FAB 10090
535 3PJS 1 A, C FAB light chain 10090
536 6OE5 3 C Motavizumab Fab Light Chain 10090
537 6OE5 5 L CR9501 Fab Light Chain 9606
538 6MAM 2 B, D, F ADI-15946 Fab Light Chain 9606
539 5O7P 2 A MF3178 FAB light chain 9606
540 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
541 4ZYP 5 E, G, I AM14 antibody light chain 9606
542 6P3S 2 B, D, G, J, N, Q, T, W Human Fab H5.28 light chain 9606
543 6RCU 4 D R5.016 light chain 9606
544 5DWU 4 L Fab - Light Chain 9606
545 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
546 6EA7 4 L, N, R ADI-15878 Fab Light Chain 9606
547 5I8H 5 F, H VRC34.01 Fab light chain 9606
548 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
549 4R4H 3 L Antibody 2.2c, Light chain 9606
550 6EA5 4 L, N, R ADI-15878 Fab Light Chain 9606
551 6YM0 3 L light chain 9606
552 5FHC 5 L Antibody 114 Fab light chain 9606
553 4XMN 6 L Antibody 87 light chain 32630
554 4XMM 8 L Antibody 57 light chain 9606
555 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
556 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
557 6ZDH 3 F, I, L EY6A light chain 9606
558 6XDG 2 D REGN10933 antibody Fab fragment light chain 10090
559 6YOR 3 C, L IgG L chain 9606
560 6Y9B 2 L, M, N Fab120.545 light chain 10090
561 6TKO 4 L Fab30 light chain 279974
562 6USF 4 L, M Fab light chain 9606
563 6UKJ 3 L Fab Light Chain 9606
564 6SNH 3 L 6AG9 Fab light chain 32630
565 6SNI 3 L 6AG9-Fab light chain 32630
566 6U1N 4 L Fab30 light chain 9606
567 6U02 2 C, F, I, L Fab-63 Light Chain 9606
568 6PZZ 2 E, G, J, L NA-80 fragment antibody light chain 9606
569 6PWC 5 L Fab30 light chain 32630
570 6PCI 3 K, L, M rEBOV-548 Fab light chain 9606
571 6OZC 3 D, L, M, N, Q, R 2G12 Fab light chain 9606
572 6OT0 5 L Fab light chain 10090
573 6OGE 2 B Pertuzumab FAB LIGHT CHAIN 9606
574 6OGE 4 D Trastuzumab FAB LIGHT CHAIN 9606
575 6QD8 1 L, Y, Z Light chain 9606
576 6NI2 4 L Fab30 Light Chain 32630
577 6NC3 4 L, T, U, V, W, X Monoclonal antibody VRC34.01 fragment antigen binding light chain 9606
578 6MLM 4 G, I, L Light chain Fv of H7.5 Fab 9606
579 6MJZ 3 L PIA174 Fab Light chain 9606
580 6E5P 1 1, 4, K, L, Q, T 2G12 Light chain 9606
581 6E1K 2 C, E cat06 light chain 9606
582 6DJP 6 F 68 light chain Fab 10090
583 6CMO 5 L Fab light chain 32630
584 6BF7 3 D, F Fab H11-E light chain 10090
585 6BF9 3 D, F Fab H11-E light chain 10090
586 6B7Z 3 D, F FAB H11 light chain 10090
587 6B70 3 D, F FAB H11-E light chain 10090
588 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
589 3CM9 3 L, M, N, O Immunoglobulin light chain 9606
590 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
591 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
592 2ESG 1 L, M Immunoglobulin A1 light chain 9606
593 1R70 1 A, C Human IgA2(m1) Light Chain 9606
594 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606